A Prospective, Randomized, Multi-Center, Double-Blind Trial to Assess the Effectiveness and Safety of Different Durations of Dual Anti-Platelet Therapy (DAPT) in Subjects Undergoing Percutaneous Coronary Intervention With the CYPHER Sirolimus-eluting Coronary Stent (CYPHER Stent).

Trial Profile

A Prospective, Randomized, Multi-Center, Double-Blind Trial to Assess the Effectiveness and Safety of Different Durations of Dual Anti-Platelet Therapy (DAPT) in Subjects Undergoing Percutaneous Coronary Intervention With the CYPHER Sirolimus-eluting Coronary Stent (CYPHER Stent).

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Oct 2013

At a glance

  • Drugs Aspirin; Clopidogrel; Prasugrel
  • Indications Stent thrombosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms CYPRESS
  • Sponsors Cordis Corporation
  • Most Recent Events

    • 25 Jan 2011 Planned end date changed from 1 May 2016 to 1 Mar 2016 as reported by ClinicalTrials.gov..
    • 25 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 08 Nov 2010 Planned End Date changed from 1 Jan 2016 to 1 May 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top